Tamara Delaine

Tamara Delaine is the Associate Director in Oral Product Development at AstraZeneca. Tamara earned a Doctor of Philosophy (PhD) in Organic Chemistry from Université Paul Sabatier from 2004 to 2007. They conducted postdoctoral research at Lund University from 2007 to 2009, focusing on the design, synthesis, and evaluation of new gatectin inhibitors, and continued similar research at Göteborgs universitet from 2009 to 2013. Prior to their current role, Tamara also held a position as a Senior Scientist in Analytical Chemistry at AstraZeneca.